Daniel Glassman

This profile gathers the share dealings of Daniel Glassman in Bradley Pharmaceuticals Inc. Over a trading history stretching from 21 February 2006 to 21 February 2008, the count stands at 17 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 21 February 2008, reports a transaction of €187k in Bradley Pharmaceuticals Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.